Stay updated on Durvalumab + Tremelumab in LS-SCLC Clinical Trial
Sign up to get notified when there's something new on the Durvalumab + Tremelumab in LS-SCLC Clinical Trial page.

Latest updates to the Durvalumab + Tremelumab in LS-SCLC Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe ClinicalTrials.gov page footer was updated from revision v3.7.2 to v3.8.0.SummaryDifference0.1%

- Check17 days agoChange DetectedA notice was added explaining that NIH websites are transitioning terminology from “Artificial Intelligence” to “Super Intelligence” and linking to transition updates and FAQs.SummaryDifference0.4%

- Check24 days agoChange DetectedThe site footer revision changed from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check31 days agoChange DetectedThe ClinicalTrials.gov footer revision label changed from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check52 days agoChange DetectedThe record history now shows a new revision entry for the study (v3.7.0), indicating an updated version of the record compared to the prior revision.SummaryDifference0.1%

- Check73 days agoChange DetectedNew revision entry v3.6.6 is added to the study record history, and the previous revision v3.6.5 is removed. This updates the page’s version history to reflect the latest release.SummaryDifference0.1%

Stay in the know with updates to Durvalumab + Tremelumab in LS-SCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab + Tremelumab in LS-SCLC Clinical Trial page.